Patents by Inventor Naranjan S. Dhalla

Naranjan S. Dhalla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6051587
    Abstract: Hypertension in mammalian patients, especially elderly human patients, derived from ingestion of NSAIDs or through the normal aging process is treated by administration to the patient of a vitamin B.sub.6 (or derivative) supplement. Where the patient requires the continued administration of an NSAID for pharmacological purposes, the NSAID is administered in conjunction with a vitamin B.sub.6 supplement. The invention further provides combination pharmaceutical combinations of an NSAID and a vitamin B.sub.6 supplement, e.g. orally administrable tablets or capsules, for use in treating such conditions.
    Type: Grant
    Filed: April 16, 1998
    Date of Patent: April 18, 2000
    Assignees: Medicure, Inc., The University of Manitoba
    Inventors: Krishnamurti Dakashinamurti, Rajat Sethi, Naranjan S. Dhalla
  • Patent number: 6043259
    Abstract: Compositions and methods for treatment and prevention of hypertrophy, hypertension, congestive heart failure, ischemic heart disease, ischemia-related conditions, such as ischemia reperfusion injury and cellular dysfunction, are described. The methods are directed to administering pharmaceutical compositions containing at least one compound selected from pyridoxal-5'-phosphate, pyridoxine, pyridoxal, and pyridoxamine.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: March 28, 2000
    Assignees: Medicure Inc., University of Manitoba
    Inventors: Naranjan S. Dhalla, Rajat Sethi, Krishnamurti Dakshinamurti